Newsroom
153 articles
Featured The FDA just recently placed investigational measures on Sarepta Therapeutics new medication “Elevidys” that has been indicated for treatment patients suffering from Duchenne muscular dystrophy (DMD), after alarming…
Featured After deep review the EMA’s safety committee (PRAC) has decided on stopping the temporary restriction of people aged 65 years or older from getting the chikungunya vaccine. Nevertheless,…
Featured On July 2, 2025, the FDA gave accelerated approval to linvoseltamab-gcpt (Lynozyfic, Regeneron Pharmaceuticals, Inc.), a targeted therapy that helps the immune system attack cancer cells. It is…
Featured The Saudi food & drug authority has been actively working towards advancing public health in kingdom through ongoing strategic initiatives aimed at strengthening the healthcare system with the…
Featured Based on recent FDA findings the use of extended-release stimulants for ADHD management in children below 6 years old has been causing weight loss & other adverse events…
Featured As of 1st of July 2025 regulations associated with the use of radioactive substances or ionizing radiation has changed to ease the process for applications in order to…
Featured Patients fighting extensive stage small cell lung cancer (SCLC) now have new hope with UK’s Medicines and Healthcare products Regulatory Agency (MHRA) recently approving serplulimab (Hetronifly) a PD-1…
Featured The European Medicines Agency (EMA) has suggested granting provisional marketing authorization for Rezdiffra (resmetirom) the first treatment in the EU for noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with modest…
Featured With UK’s continuing efforts in providing better healthcare services & treatments for patients, comes the new initiative of providing at home cervical testing kits to screen for the…
Featured On 24 June, the United Kingdom was the first country to join the HealthAI Global Regulatory Network, a new international initiative to ensure the safe and effective use…
Featured Finding a treatment for hematological malignancies can be a challenging as it mainly depends on finding a suitable donor & if they are lucky enough to find a…
Featured Scopolamine transdermal patches were approved by the FDA in the 1970s for managing nausea and vomiting caused by motion sickness; later, they also got FDA approval for recovery…
Featured In a significant advancement for lymphoma treatment, the FDA has approved Monjuvi (tafasitamab-cxix) in combination with lenalidomide and rituximab for adults with relapsed or refractory follicular lymphoma (FL).…
Featured With continuous efforts to find new cancer treatments, comes to life a new ultrasound technology developed by a US based company called HistoSonics the device works by destroying…
Featured The EMA has published a draft guideline for public consultation that offers recommendations on how to include and/or continue pregnant and breastfeeding individuals in clinical trials. The aim…
Talk to our experts and get tailored solutions to help you stay compliant and move forward with confidence.
Submit RFI/RFP
Request Consultation
Submit RFI/RFP